The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors
EMA对Asciminib用于治疗既往接受过至少两种酪氨酸激酶抑制剂治疗的慢性期费城染色体阳性慢性粒细胞白血病成年患者的评估
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad119
Tesileanu, C Mircea S; Michaleas, Sotirios; Gonzalo Ruiz, Rocio; Mariz, Segundo; Fabriek, Babs O; van Hennik, Paula B; Dedorath, Jutta; Dekic, Bruna; Unkrig, Christoph; Brandt, Andreas; Koenig, Janet; Enzmann, Harald; Delgado, Julio; Pignatti, Francesco
